CLARUS THERAPEUTICS HOLDINGS (CRXT) Stock Analyst Earnings Estimates
NASDAQ:CRXT - Nasdaq - US18271L1070 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.369M | 13.957M 119.14% | 19.32M 38.43% | 33.166M 71.66% | 51.784M 56.14% | 83.211M 60.69% | 136.384M 63.90% | ||
| EBITDA YoY % growth | -17.872M | -47.159M -163.87% | -39.707M 15.80% | -49.572M -24.84% | -44.37M 10.49% | -15.606M 64.83% | -21.062M -34.96% | -28.994M -37.66% | |
| EBIT YoY % growth | -17.876M | -47.177M -163.91% | -39.732M 15.78% | -36.733M 7.55% | -17.684M 51.86% | -4.75M 73.14% | -7.568M -59.31% | -12.298M -62.50% | |
| Operating Margin | N/A | -740.73% | -284.67% | -190.13% | -53.32% | -9.17% | -9.09% | -9.02% | |
| EPS YoY % growth | N/A | N/A | N/A | -1.02 87.39% | -0.43 58.19% | -0.13 70.40% | -0.20 -61.08% | -0.33 -64.30% |
All data in USD
| Q3 / 22 | Q4 / 22 | |
|---|---|---|
| EPS Q2Q % growth | -0.22 14.58% | -0.16 15.45% |
| Revenue Q2Q % growth | 6.013M 40.30% | 7.271M 59.37% |
| EBITDA Q2Q % growth | -11.73M -39.39% | -11.73M -61.90% |
| EBIT Q2Q % growth | -9.773M -15.89% | -8.414M -15.74% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | -0.21 | -0.29 | 0.08 | 28.20% |
| Q1 2022 Q2Q % growth | -0.61 | -0.41 | -0.20 | -47.66% |
| Q4 2021 Q2Q % growth | -0.19 | -0.69 | 0.50 | 72.61% |
| Q3 2021 Q2Q % growth | -0.26 | -0.82 | 0.56 | 68.44% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2022 Q2Q % growth | 4.05M -20.73% | 5.199M | -1.149M | -22.10% |
| Q1 2022 Q2Q % growth | 4.011M 72.15% | 5.61M | -1.599M | -28.50% |
| Q4 2021 Q2Q % growth | 4.562M 88.05% | 4.733M | -170.8K | -3.61% |
| Q3 2021 Q2Q % growth | 4.286M 92.72% | 3.235M | 1.051M | 32.50% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |